What move does the options market price into Protalix BioTherapeutics's report?

Implied ±4.3%, either direction.

How often does Protalix BioTherapeutics move more than the options market prices?

2 of the last 8 reports moved at least as far as the implied move.

PLXNYSEBiological Products, (No Diagnostic Substances)

Protalix BioTherapeutics, Inc. (PLX) earnings date, market-implied expected move, and options open interest by expiry

2.59

+0.03 · +1.09%

post 2.59 +0.01%

Closed16:00 ET

Open2.48Volume289,039Mkt cap$210.3MP/E10.35EPS0.25

Day2.48 – 2.6094%52-wk1.65 – 3.1961%

PLX

Protalix BioTherapeutics, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±4.3%implied · report alone

8Q avg ±13.6%·×0.32·cheap

2.502.72

straddle ±17.1%

spot 2.61exp Nov 20ATM strike 2.5ATM straddle 0.53IV 118%

Nov 3 closereport share · term structure

Expected move

Inputs

Next report

Nov 10

before open · in 7 days

confirmedQ3 FY26

Calendar

Next report

Last report

+7.82%

vs ±12.4% implied · ×0.63

shaded = implied · ▲▼ = realized

Aug 12 '26 · confirmed

Implied vs realized

Linked news

6hPFE · customerPfizer names Cecile Guegan CFO; $1,300,000 base, $1,300,000 target incentive

News

Largest filed tie

13F top-10 QoQ

+13.96%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

100 managers

Top fund weight

0.01%

PLX weight · IWM

N-PORTJun 30 '26

2 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Protalix BioTherapeutics (PLX) reports on Nov 10 before open (confirmed date).

Implied vs realized

8 reports

2 of 8≥ implied

avg implied: ±20.5%
avg realized: ±13.6%

Nov 14 '24Nov 14 '24confirmed±18.5%▲+13.71%×0.74

Mar 17 '25Mar 17 '25confirmed±15.1%▲+9.38%×0.62

May 9 '25May 9 '25confirmed±14.0%▼−40.48%×2.88

Aug 14 '25Aug 14 '25confirmed±43.2%▼−5.59%×0.13

Q3 FY25Nov 13 '25confirmed±28.3%▼−9.81%×0.35

Q1 FY26Mar 18 '26confirmed±15.2%▼−20.79%×1.37

May 13 '26May 13 '26confirmed±17.0%▲+1.05%×0.06

Q2 FY26Aug 12 '26confirmed±12.4%▲+7.82%×0.63

quarterimplied−45%0+45%realized×

Q2 FY26±12.4%▲+7.82%×0.63

May '26±17.0%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 2 expiries · Oct 26 close

0.30OI · 2 expiries · Oct 26 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

8100%Nov 2017d2,677−1%

247+4%Feb 19108d0.064,227−1%0.06

ExpiryPutsCallsP/C

Nov 2017d8100%2,677−1%0.30

Feb 19108d247+4%4,227−1%0.06

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±17.1%

Funds 2

IWM±0.0%

UWM±0.0%

Dashed = straddleMethod Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

as filedQ2 FY26

18.98%as filednet margin · revenue −41.05% QoQ · +27.07% YoY

Revenue

$20M−41.05% QoQ

Gross profit

$12M−59.04% QoQ

60.99% margin

Operating income

$5M−77.91% QoQ

23.48% margin

Pre-tax income

$5M−77.01% QoQ

Net income

$4M−79.38% QoQ

18.98% margin

Cost of revenue

$8M+88.08% QoQ

Operating expenses

$7M−11.97% QoQ

R&D $4M

SG&A $3M

Tax

$1M−61.65% QoQ

Other income

$188,000+3860.00% QoQ

Revenue$20M−41.05%

Gross profit

$12M−59.04%

60.99% margin

Operating income

$5M−77.91%

23.48% margin

Pre-tax income

$5M−77.01%

Net income

$4M−79.38%

18.98% margin

Cost of revenue

$8M+88.08%

Operating expenses

$7M−11.97%

R&D $4M

SG&A $3M

Other income$188,000+3860.00%

Tax$1M−61.65%

flow · deduction · inflow · signed % = QoQSource: SEC filings · standardized · QE Jun 30 '26 · width = $

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 3 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

PPI ×2.14· ±6.1% vs ±2.9% · 10 releases

eventrelease day|move|up · n×base

PPIproducer prices±6.1%7 of 10×2.14

FOMCrate decision±3.5%10 of 24×1.22

NFPjobs report±2.9%7 of 10×1.02

CPIconsumer prices±2.8%4 of 10×0.96

CPROFcorporate profits±1.9%6 of 12×0.68

GDPgross domestic product±1.9%10 of 19×0.66

PCEpersonal income & outlays±1.7%9 of 19×0.61

Bar = avg |move| to ±7% · tick = ±2.9% avg day · ×base = |move| ÷ ±2.9% · min 6 releases

Earnings history

EPS 0.05 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 12 '26 · confirmed	0.05	—
Q1 FY26	Mar 18 '26 · confirmed	0.22	—
Q3 FY25	Nov 13 '25 · confirmed	0.03	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod